Want to see HQY full AI Analyst Report?
HQY Stock Chart & Stats
$99.05
$4.41(4.67%)
At close: 4:00 PM EDT
$99.05
$4.41(4.67%)
Day’s Range― - ―
52-Week Range$72.76 - $107.62
Previous CloseN/A
Volume702.99K
Average Volume (3M)915.55K
Market Cap
$8.81B
Enterprise Value$7.69K
Total Cash (Recent Filing)$265.37M
Total Debt (Recent Filing)$984.68M
Price to Earnings (P/E)39.0
Beta0.91
Next Earnings
Aug 27, 2026EPS Estimate
1.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.70
Shares Outstanding83,602,160
10 Day Avg. Volume788,155
30 Day Avg. Volume915,554
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)3.50
Price to Sales (P/S)5.62
P/FCF Ratio16.21
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$114.00Price Target Upside15.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)4.72
Revenue Forecast (FY)$1.42B
Bulls Say, Bears Say
Bulls Say
HSA Account And Asset GrowthAbove-market HSA growth and strong new-account additions indicate share gains and expanding platform scale. More accounts and assets should support recurring administration, custodial, investment and payment revenue over the next several quarters.
Profitability And Cash GenerationThe multi-year shift from losses to solid profitability, wider margins and free cash flow broadly matching net income indicate improved earnings quality. This provides internally generated capital for technology investment, debt reduction and acquisitions.
Digital Operating LeverageGreater mobile engagement can strengthen member retention and platform usage, while AI and self-service reduce labor intensity as volumes grow. If sustained, these capabilities can support scalable service delivery and margin expansion.
Bears Say
HSA Cash Yield ExposureCustodial income depends on cash yields and contract placement, so FY27 maturities create meaningful earnings sensitivity to timing and rates. Hedging reduces volatility but does not eliminate repricing and reinvestment risk.
Temporary Cost BenefitsSome recent margin improvement came from unusually favorable claims utilization and lower fraud reimbursements rather than structural efficiency alone. Reversal could raise service costs and make future margin comparisons less favorable.
Balance Sheet Reporting UncertaintyThe apparent debt reduction makes leverage look conservative, but the magnitude of the change requires confirmation. If driven by classification or reporting differences rather than repayment, financial flexibility and risk may be overstated.
HQY FAQ
What was Healthequity’s price range in the past 12 months?
Healthequity lowest stock price was $72.76 and its highest was $107.62 in the past 12 months.
What is Healthequity’s market cap?
Healthequity’s market cap is $8.81B.
When is Healthequity’s upcoming earnings report date?
Healthequity’s upcoming earnings report date is Aug 27, 2026 which is in 2 days.
How were Healthequity’s earnings last quarter?
Healthequity released its earnings results on May 28, 2026. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.115 by $0.125.
Is Healthequity overvalued?
According to Wall Street analysts Healthequity’s price is currently Undervalued.
Does Healthequity pay dividends?
Healthequity does not currently pay dividends.
What is Healthequity’s EPS estimate?
Healthequity’s EPS estimate is 1.19.
How many shares outstanding does Healthequity have?
Healthequity has 83,602,160 shares outstanding.
What happened to Healthequity’s price movement after its last earnings report?
Healthequity reported an EPS of $1.24 in its last earnings report, beating expectations of $1.115. Following the earnings report the stock price went down -2.795%.
Which hedge fund is a major shareholder of Healthequity?
Currently, no hedge funds are holding shares in HQY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Healthequity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$114.00 (15.09% Upside)
$114.00 (15.09% Upside)
Blogger Sentiment
Bullish
HQY Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 191.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 7.7%
Last 30 Days ▼ 7.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.27%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-3.22%
Trailing 12-Months
Company Description
Healthequity
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.
HQY Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized solid execution: revenue and gross profit records, margin expansion, strong adjusted EBITDA growth (+17% YoY) and raised guidance, supported by healthy HSA account/asset growth, digital engagement gains, AI-driven service efficiencies, and an expanded $1B share repurchase authorization. Lowlights were mostly timing/one-time items (breakage fee, lower fraud reimbursements), early-stage marketplace revenue (not yet material), exposure in HSA cash maturities and interest-rate timing, and caution that some service-cost improvements may be seasonal or temporary. Overall, the positives around durable account/asset growth, margin expansion, cash generation and strategic initiatives materially outweigh the cautions and one-offs.View all HQY earnings summariesHQY Revenue Breakdown
49.92% Service revenue
32.85% Custodial revenue
17.23% Interchange revenue

HQY Stock 12 Month Forecast
Average Price Target
$114.00
▲(15.09% Upside)
Technical Analysis
Omnicell
―
―
Doximity
―
BrightSpring Health Services, Inc.
―
Hinge Health, Inc. Class A
―
Ownership Overview
2.06% Insiders
35.54% Mutual Funds
33.49% Other Institutional Investors
2.36% Public Companies and
Individual Investors









